Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Feb 14, 2025; 31(6): 101163
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.101163
Table 1 Pretreatment baseline data of patients in both groups (measured data)
Variable
PC group (n = 54)
Conservative group (n = 29)
t/z value
P value
Age (years)62.7 ± 20.6355.55 ± 15.921.6240.108
BMI25.31 ± 3.3424.62 ± 2.470.9830.329
Hospitalization (days)17.28 ± 9.7215.9 ± 4.360.7260.47
Temperature (°C)37.5 (36.8-38.18)37.8 (37.3-38.5)-0.5130.130
WBC (× 109/L)13.6 (10.87-16.62)12.6 (8.95-16.73)-0.8170.414
NEU (%)88.2 (82.8-90.9)85.1 (78.6-88.95)-1.6620.097
ALT (U/L)49 (24.68-100.45)35.9 (28.5-48.9)-1.0270.305
GGT (U/L)106.5 (51.5-238)71 (52.5-126.5)-1.1410.254
TBIL (μmol/L)29.35 (17.57-54)22.2 (17.4-29.5)-1.9440.052
DBIL (μmol/L)2.75 (0-12.95)0 (0-4.65)-1.5620.118
IBIL (μmol/L)13.9 (8.58-27)11.7 (8.7-13.4)-1.8290.067
AMS (U/L)394.5 (151.25-1060)211 (101.5-650)-1.7050.088
CTSI3 (3-5)3 (3-3)-0.2820.778